Status:
TERMINATED
A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
Lead Sponsor:
Washington University School of Medicine
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Patients with head and neck cancer and are schedule to receive standard radiation therapy known as IMRT to treat cancer
Detailed Description
In this study, we will plan additional measurements of the position of the patient's organs weekly during radiation treatment. We will analyze these measurements in order to evaluate whether we need t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age \>= 18
- Karnofsky Performance Status of \>= 60
- New diagnosis of head-and-neck cancer, all subsites included (i.e. nasopharynx, oropharynx, oral cavity, hypopharynx, larynx.)
- All stages with measurable gross disease (\>= 1.0 cm) by CT imaging
- Pathologic confirmation of squamous cell carcinoma by biopsy or cytology
- Signed study-specific consent form
- Sequential or concurrent chemotherapy is allowed but not mandated. (no chemotherapy is allowed if patient is judged not to be a candidate for chemotherapy by the medical oncologist)
- Exclusion Criteria
- Age \< 18
- Karnofsky Performance Status \< 60
- Radiographic or pathologic evidence of distant metastatic disease (i.e. other than cervical lymph nodes)
- Prior radiation therapy to the head-and-neck region
Exclusion
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00608751
Start Date
January 1 2007
End Date
January 1 2008
Last Update
May 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110